Letting ill children float their worries away - Boston Globe
Gwen Lorimier, 6 years old and back at MassGeneral Hospital for Children for yet another stay, perks up when she hears a familiar jingling outside her door. It's the sound of Joan Drescher making her way down the halls with her "Imagination Kart

CAROLINE: IT'S NOW MY TIME - New York Post
It's "her time" to get into the family business. Caroline Kennedy's high-profile appointment to Barack Obama 's vice-presidential search team was orchestrated in a deal brokered by her famous uncle, Massachusetts Sen. Ted Kennedy, in exchange for his

Test can find tiny tumor level in blood - Boston Globe
Boston researchers have developed a test that can identify minute amounts of tumor cells floating in the blood of cancer patients, a discovery that could lead to better treatments with fewer side effects. The technology, invented at Massachusetts

Introgen cuts 29% of jobs as it moves to market cancer therapy - MSN MoneyCentral
Introgen Therapeutics Inc. is reducing its development staff to focus on regulatory review and commercial activities. The pharmaceutical company that is working on cancer therapies plans to cut 20 of its 70 employees. The jobs eliminated are mainly

Liver donor's family, recipient unite online - Los Angeles Times
PITTSBURGH — They were precocious toddlers, both blond-haired and blue-eyed, separated by a thousand miles between Miami and a small Kentucky town. The two girls would never meet, but would be brought together through unthinkable tragedy: Trine

Test can find tiny tumor level in blood - Boston Globe
Boston researchers have developed a test that can identify minute amounts of tumor cells floating in the blood of cancer patients, a discovery that could lead to better treatments with fewer side effects. The technology, invented at Massachusetts

Counting tumor cells in blood predicts treatment benefit in prostate - PhysOrg
Counting the number of tumor cells circulating in the bloodstream of patients with castration-resistant prostate cancer can accurately predict how well they are responding to treatment, new results show. At the ESMO Conference Lugano (ECLU) organized